Contera Pharma A/S

Health Care · Biotechnology
Clinical trials: 3No open roles listed
Data updated Nov 21, 2026Full reportReport a mistake

Facts

as of Nov 21, 2026

AboutContera Pharma Learn about us Foundation and core beliefs Our Ambition Neurological disorders are devastating and complex conditions with limited treatment options.

Employees
201-500estimated range
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

Products

Products →

Contera Pharma A/S has 3 clinical trials on record, 0 under way.

Clinical trials
Open-Label Extension Study of ASTORIA
phase 2 · stopped or withdrawn · 6 participants · Dyskinesias
Jan 2024
A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia
phase 2 · completed · 89 participants · Dyskinesias
Jul 2019
Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia
phase 2 · completed · 30 participants · as a collaborator · Parkinson's Disease; Levodopa Induced Dyskinesia (LID)
May 2015
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices